Quarterly report pursuant to Section 13 or 15(d)

Organization and Basis of Presentation (Details Narrative)

v3.23.1
Organization and Basis of Presentation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 17, 2021
Mar. 31, 2023
Dec. 31, 2021
Dec. 31, 2022
Accumulated deficit   $ (47,800)    
Common stock shares, par value   $ 0.0001   $ 0.0001
Cash and cash equivalents       $ 8,800
Net Cash Used In Operation   $ 880 $ 1,600  
Sale of stock 160,714      
Warrant exercise price   $ 112.00    
Warrant exercise price   $ 0.0001    
Initial Public Offering [Member]        
Common stock shares, par value $ 0.0001      
Warrants to purchase one share of common stock 160,714      
Warrant exercise price $ 112.00      
Combined Offering Price $ 112.00      
Warrants issued 24,106 184,820    
Option exercise price $ 112.00      
Gross Proceeds from warrants purchase of common stock $ 15,400 $ 5,000    
Issuance costs $ 2,600